TTK HealthcareBOM:507747 +0.62%72 Gross Margin % is 51.28% as of Mar. 2026, which is 5% below its 10-year median of 53.99. GuruFocus rates BOM:507747 with a GF Score™ of 72/100 and a GF Value™ of ₹1,454.14 (Significantly Undervalued). The stock has 1 warning sign investors should review. Among 938 Drug Manufacturers companies, TTK Healthcare ranks better than 57.25% on this metric.
The historical rank and industry rank for TTK Healthcare's Gross Margin % or its related term are showing as below:
BOM:507747'
s Gross Margin % Range Over the Past 10 Years
Min: 51.36 Med: 53.99 Max: 59.41
Current: 52.93
During the past 13 years, the highestGross Margin % of TTK Healthcare was 59.41%. The lowest was 51.36%. And the median was 53.99%.
BOM:507747's Gross Margin % is ranked better than 57.25% of 938
companies
in the Drug Manufacturers industry
Industry Median: 48.54
vs BOM:507747: 52.93
TTK Healthcare had a gross margin of 51.28% for the quarter that ended in Mar. 2026 => Durable competitive advantage
The 5-Year average Growth Rate of Gross Margin for TTK Healthcare was -0.30% per year.
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
TTK Healthcare had a gross margin of 51.28% for the quarter that ended in Mar. 2026 => Durable competitive advantage
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
TTK Healthcare Gross Margin % Related Terms
TTK Healthcare Gross Margin % Historical Data
* Premium members only.
The historical data trend for TTK Healthcare's Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:507747 vs LLY, JNJ, ABBV: Gross Margin % Comparison
For the Drug Manufacturers - General subindustry, TTK Healthcare's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
TTK Healthcare Gross Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, TTK Healthcare's Gross Margin % distribution charts can be found below:
* The bar in red indicates where TTK Healthcare's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
TTK Healthcare (BOM:507747) has a Gross Margin % of 51.28% as of Mar. 2026. Gross margin is the ratio of total gross profit to net sales. View historical data on TTK Healthcare and its competitors. This is near median its historical median of 53.99. Over the past decade, TTK Healthcare's Gross Margin % has ranged from 51.36 to 59.41. According to the industry distribution chart, TTK Healthcare ranks #401 out of 938 companies in the Drug Manufacturers industry, placing it in the top 42.8%.
Is TTK Healthcare's Gross Margin % too high?
TTK Healthcare's current Gross Margin % of 51.28% is near median its 10-year median of 53.99. Over the past 10 years, this metric has ranged from a low of 51.36 to a high of 59.41. The Drug Manufacturers industry median Gross Margin % is 48.54. TTK Healthcare's value of 51.28% is 5.6% above this industry median. Based on the distribution chart, TTK Healthcare ranks #401 out of 938 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, TTK Healthcare has a GF Score™ of 72/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does TTK Healthcare's Gross Margin % compare to LLY and JNJ?
According to the Drug Manufacturers industry distribution chart, TTK Healthcare ranks #401 out of 938 companies for Gross Margin %. This puts TTK Healthcare in the upper half of its industry. The industry median Gross Margin % is 48.54. TTK Healthcare's value of 51.28% is 5.6% above this benchmark. Historically, TTK Healthcare's own Gross Margin % has ranged from 51.36 to 59.41 over the past decade. While the company's 10-year median is 53.99 vs. the industry median of 48.54, TTK Healthcare has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Drug Manufacturers company?
The median Gross Margin % among Drug Manufacturers companies is 48.54, based on 938 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. TTK Healthcare's current Gross Margin % of 51.28% is 5.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on TTK Healthcare and its competitors. For the Drug Manufacturers industry, the median Gross Margin % is 48.54 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. TTK Healthcare's current Gross Margin % is 51.28%, which is near median its own 10-year median of 53.99. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is TTK Healthcare stock overvalued right now?
Based on GuruFocus' analysis, TTK Healthcare (BOM:507747) is currently considered Significantly Undervalued. The stock's GF Value™ is ₹1,454.14, compared to a current price of ₹922.00 — trading 36.6% below its estimated fair value. The current Gross Margin % is 51.28%, which is near median its 10-year median of 53.99 and 5.6% above the Drug Manufacturers industry median of 48.54. TTK Healthcare's overall GF Score™ is 72/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For TTK Healthcare (BOM:507747), the current Gross Margin % is 51.28% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is TTK Healthcare (BOM:507747) Overvalued in 2026?
Based on GuruFocus' analysis, TTK Healthcare stock appears to be undervalued.
The current stock price of ₹922.00 is trading 36.6% below its estimated GF Value™ of ₹1,454.14.
GuruFocus considers TTK Healthcare to be Significantly Undervalued.
Key valuation signals for BOM:507747:
Gross Margin %: 51.28% (near median its 10-year median of 53.99)
GF Value™: ₹1,454.14 vs. price of ₹922.00 (36.6% below fair value)
Industry Position: 5.6% above the Drug Manufacturers median (#401 of 938)
No single metric tells the full story. See the BOM:507747 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
TTK Healthcare Ltd is an Indian pharmaceutical company. The company's operating segment includes Animal Welfare, Consumer Products, Medical Devices, Protective Devices, Foods Division, and Others. Its Animal Welfare segment includes products for both Human and Veterinary use. The Consumer Products comprises of marketing and distribution of Woodwards's Gripe Water, EVA Range of Cosmetics, Good Home range of Scrubbers, Air Fresheners and others. Protective Devices comprises of manufacturing and marketing of Male Contraceptives and other allied products. It generates maximum revenue from the Pharmaceuticals segment. Geographically, it derives a majority of revenue from India.
72GF Score
Get the complete analysis for BOM:507747
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:507747 has been successfully added to your 
